BiVictriX focuses on developing and licensing bispecific antibody drug conjugates.
Business Model:
Revenue: $0
Employees: 1-10
Address: Bio Hub, Alderley Park
City: Alderley Edge
State: england
Zip: SK10 4TG
Country: GB
BiVictriX focuses on developing and licensing bispecific antibody drug conjugates.
Contact Phone:
Contact Email:
Listed Exchange:
London Stock Exchange
Ticker Symbol:
BVX
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 8/2021 | IPO | $10.4M | 1/2017 | Seed | $533.4k | 8/2019 | Seed Round | 2 | - |
Alderley Park Ventures Development Bank of Wales Alderley Park Ventures Development Bank of Wales |
11/2020 | Equity | $1.3M | 8/2019 | Seed Round | 2 | - |
Alderley Park Ventures Development Bank of Wales Alderley Park Ventures Development Bank of Wales |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|